Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 4008-4013, July 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darling, G.
Right arrow Articles by Norton, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darling, G.
Right arrow Articles by Norton, J. A.

Cachectic Effects of Recombinant Human Tumor Necrosis Factor in Rats

Gail Darling, Douglas L. Fraker, J. Christian Jensen, Catherine M. Gorschboth and Jeffrey A. Norton1

Surgical Metabolism Section, Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892

Treatment of rats with either intermittent bolus i.v. injections or continuous i.v. infusions of the same sublethal daily dose of tumor necrosis factor (TNF) results in decreased food intake and decreased nitrogen balance compared to saline-treated control rats. After 4 days of treatment, rats treated with intermittent bolus doses of TNF develop tolerance to the nutritional effects and consume normal amounts of food and have nitrogen balance similar to those of saline treated rats. Rats receiving the continuous infusion of TNF do not. Rats treated with both routes of TNF lose more weight than pair fed rats who eat the same mean amount as the continuous TNF treated group. In addition, 56% of rats receiving continuous infusion TNF die during the 8-day experimental period while rats receiving either intermittent bolus TNF or similar food intake (pair fed) do not. Body composition studies of rats that completed the 8 days of treatment indicate that rats receiving either continuous infusion or intermittent bolus TNF have increased percentages of body water and reduced percentages of body solid compared to saline treated control rats. Rats pair fed to the food intake of continuous TNF treated rats also had increased percentages of body water and reduced percentages of body solid, but changes were significantly less than those observed in continuous TNF infused rats. Continuous TNF infusion reduced total body nitrogen and potassium while pair feeding did not reduce potassium and reduced nitrogen to a lesser degree. Pair feeding and continuous TNF infusion reduced total body fat to a similar extent. Twice a day administration of TNF resulted in lesser changes in carcass water, solid, nitrogen, lipid, and potassium than continuous infusion of the same dose of TNF. The results indicate that continuous infusion of TNF can produce anorexia, weight loss, edema, loss of body protein, lipid and cell mass, and lethality which is markedly ameliorated with bolus doses of TNF. The findings are consistent with the hypothesis that slow continuous secretion of sublethal amounts of TNF may mediate cancer cachexia.

1 To whom requests for reprints should be addressed, at Surgical Metabolism Section, Surgery Branch, National Cancer Institute, NIH, Building 10, Room 2B07, Bethesda, MD 20892.

Received 6/23/89. Revised 3/15/90.


This article has been cited by other articles:


Home page
JPEN J Parenter Enteral NutrHome page
Y.-J. Nai, Z.-W. Jiang, Z.-M. Wang, N. Li, and J.-S. Li
Prevention of Cancer Cachexia by Pyrrolidine Dithiocarbamate (PDTC) in Colon 26 Tumor-Bearing Mice
JPEN J Parenter Enteral Nutr, January 1, 2007; 31(1): 18 - 25.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Elander, L. Engstrom, M. Hallbeck, and A. Blomqvist
IL-1beta and LPS induce anorexia by distinct mechanisms differentially dependent on microsomal prostaglandin E synthase-1
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R258 - R267.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
D. H. Esper and W. A. Harb
The Cancer Cachexia Syndrome: A Review of Metabolic and Clinical Manifestations
Nutr Clin Pract, August 1, 2005; 20(4): 369 - 376.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
J. F. FRIEDMAN, H. K. KANZARIA, L. P. ACOSTA, G. C. LANGDON, D. L. MANALO, H. WU, R. M. OLVEDA, S. T. MCGARVEY, and J. D. KURTIS
RELATIONSHIP BETWEEN SCHISTOSOMA JAPONICUM AND NUTRITIONAL STATUS AMONG CHILDREN AND YOUNG ADULTS IN LEYTE, THE PHILIPPINES
Am J Trop Med Hyg, May 1, 2005; 72(5): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. M. Rizk, D. Stammsen, G. Preibisch, and J. Eckel
Leptin and Tumor Necrosis Factor-{{alpha}} Induce the Tyrosine Phosphorylation of Signal Transducer and Activator of Transcription Proteins in the Hypothalamus of Normal Rats In Vivo
Endocrinology, July 1, 2001; 142(7): 3027 - 3032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.